Other OTC - Delayed Quote USD

Applied Biosciences Corp. (APPB)

0.0002 0.0000 (0.00%)
At close: October 23 at 9:30 AM EDT
Loading Chart for APPB
DELL
  • Previous Close 0.0002
  • Open 0.0002
  • Bid --
  • Ask --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0002 - 0.0009
  • Volume 895
  • Avg. Volume 0
  • Market Cap (intraday) 70,505
  • Beta (5Y Monthly) 1,443.15
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.

www.appliedbiocorp.com

25

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: APPB

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

APPB
0.00%
S&P 500
6.33%

1-Year Return

APPB
77.78%
S&P 500
22.70%

3-Year Return

APPB
99.90%
S&P 500
21.33%

5-Year Return

APPB
99.98%
S&P 500
72.88%

Compare To: APPB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: APPB

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.08

  • Enterprise Value/EBITDA

    -0.03

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -64.15%

  • Return on Equity (ttm)

    -221.59%

  • Revenue (ttm)

    859.86k

  • Net Income Avi to Common (ttm)

    -2.79M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.27k

  • Total Debt/Equity (mrq)

    100.97%

  • Levered Free Cash Flow (ttm)

    -89.62k

Company Insights: APPB